Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04725097 · ClinicalTrials.gov registry record
A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2,821
- Enrollment target
NCT04725097: Clinical Trial study, sponsored by Mayo Clinic.
NCT04725097 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2,821 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04725097 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2,821 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,821 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04725097
The ClinicalTrials.gov registry entry for NCT04725097 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2,821 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04725097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04725097 about?
NCT04725097 is a clinical study titled "A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection". The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.
What is the current status of trial NCT04725097?
This trial is currently terminated. The enrollment target is 2,821 participants. The study started on 2020-12-10. Estimated completion is 2021-06-03.
Who is sponsoring clinical trial NCT04725097?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.